Results
11
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
11 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
INFINITY | RON 2.43 | -0.8% | 28.6% | RON 1.2b | n/a | PE4.7x | n/a | 0% | Diversified Financials | ||
EVER | RON 1.47 | -1.0% | 17.1% | RON 1.3b | n/a | PE4.7x | n/a | 6.1% | Diversified Financials | ||
PRBU | RON 1,100.00 | 0% | -18.5% | RON 653.4m | n/a | PE21.5x | n/a | 4.8% | Real Estate Management and Development | ||
CMVX | RON 78.00 | -3.1% | n/a | RON 909.2m | n/a | PE7x | n/a | 13.7% | Transportation | ||
SOCP | RON 1.70 | 0.6% | -17.7% | RON 1.1b | n/a | PE8.9x | n/a | 4.3% | Transportation | ||
ARS | RON 8.34 | -3.0% | -4.1% | RON 1.3b | n/a | PE14x | n/a | 2.5% | Capital Goods | ||
BIO | RON 0.73 | -1.9% | -9.7% | RON 717.3m | n/a | PE8.9x | n/a | 4.3% | Pharmaceuticals & Biotech | ||
SCD | RON 4.52 | 0% | 61.4% | RON 3.2b | n/a | PE11.6x | n/a | 0% | Pharmaceuticals & Biotech | ||
TEL | RON 38.60 | -2.8% | 34.5% | RON 2.8b | RON 35.90 | PE6.7x | S-13.1% | 0.7% | Utilities | ||
SFG | RON 39.30 | -2.5% | 47.2% | RON 1.5b | RON 35.60 | PE14x | E11.3% | 5.3% | Consumer Services | ||
EL | RON 12.70 | -5.9% | 11.4% | RON 4.3b | RON 14.98 | PE7.4x | E4.2% | 0.9% | Utilities |